Watch the recorded webcast from Egetis’ Capital Markets Day

Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatment of serious diseases with significant unmet medical needs in the orphan drug segment

Upcoming event

Latest presentation

Latest Report

November 8, 2022

Q3 Report 2022

Calendar and upcoming reports

December 1, 2022

Erik Penser Bank Temadag - Healthcare

December 15, 2022

DNB Nordic Healthcare Conference

February 22, 2023

Year-end Report Q4 2022

Share

Twitter
LinkedIn

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@egetis.com